Q3EBITDAgrowth of 44% YoY was 20% above our and consensus estimates, however higher tax rates of 39% (vs. 25% assumed as guided; now guidance revised to 28%) resulted in largely in-line PAT. While strong growth in US (8% QoQ) was led by improved market share of gGlumetza; growth in India (12% YoY) a..